Stay updated with breaking news from Evolutionary Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Doctors diagnosed Christopher Gregg, Ph.D., member of the Nuclear Control of Cell Growth and Differentiation Program at Huntsman Cancer Institute at the University of Utah (the U) and neuroscientist and professor of neurobiology and human genetics at the U, with stage 4 metastatic breast cancer in 2018.
The relatively new discipline of evolutionary medicine is making strides in the fields of cancer treatment and antibacterial resistance.
Damon R. Reed, MD, discusses a phase 2 study of fam-trastuzumab deruxtecan-nxki in adolescent and young adult patients with recurrent HER2-positive osteosarcoma.
Researchers in the Center of Excellence for Evolutionary Therapy at Moffitt Cancer Center have been investigating an alternative treatment approach called adapt
Most cancer treatments are based on using the maximum tolerated dose of a drug to kill as many cancer cells as possible.